staurosporine has been researched along with Cancer of Ovary in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, I; Chhikara, BS; Kumar, A; Mandal, D; Parang, K; Tiwari, R | 1 |
| Csuk, R; Siewert, B | 1 |
| Hu, S; Jin, Y; Li, S; Ma, W; Ren, D; Wu, N; Xiao, S | 1 |
| Alsamman, K; El-Masry, OS | 1 |
| Li, X; Liao, QP | 1 |
| Baba, T; Berchuck, A; Cory Barnett, J; Fujii, S; Kondoh, E; Konishi, I; Matsumura, N; Mori, S; Murphy, SK; Whitaker, RS; Yamaguchi, K | 1 |
| Auersperg, N; Choi, KC; Leung, PC; Tai, CJ; Tzeng, CR | 1 |
| De Geyter, C; De Geyter, M; Dürrenberger, M; Vollmer, M; Zhang, H | 1 |
| Brown, S; Chen, EX; Dancey, JE; Hirte, HW; Hotte, SJ; Moore, M; Oza, A; Pond, GR; Winquist, EW | 1 |
| Altevogt, P; Gast, D; Gutwein, P; Issa, Y; Sanderson, MP; Stoeck, A | 1 |
| Chung, WH; Han, K; Han, KT; Kim, M; Kim, Y; Lim, J; Park, IY | 1 |
| Brown, S; Carey, MS; Dancey, JE; Hirte, HW; Hotte, SJ; Oza, AM; Pond, GR; Tsao, MS; Welch, S | 1 |
| Gregory-Bass, RC; Liu, D; Matthews, R; Olatinwo, M; Stiles, JK; Thomas, K; Thompson, WE; Tsang, B; Xu, W | 1 |
| Chorvath, B; Duraj, J; Hunakova, L; Novotny, L; Sedlak, J | 1 |
| Chorváth, B; Novotný, L; Sedlák, J | 1 |
| Collins, JL; Manning, K; Powell, CB | 1 |
| Aghajanian, C; Husain, A; Rosales, N; Schwartz, GK; Spriggs, DR; Yan, XJ | 1 |
| Idei, T; Igarashi, N; Kikuchi, A; Matukawa, T; Nakayama, Y; Ohtani, K; Sakamoto, H; Satoh, K | 1 |
| Novotny, L; Rauko, P; Szekeres, T; Yalowitz, JA | 1 |
| Andrews, PA; Howell, SB; Isonishi, S | 1 |
1 review(s) available for staurosporine and Cancer of Ovary
| Article | Year |
|---|---|
Antitumor activity of benzamide riboside in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; DNA Replication; Female; Humans; IMP Dehydrogenase; In Vitro Techniques; Leukemia L1210; Nucleosides; Ovarian Neoplasms; Staurosporine; Survival Rate | 2002 |
2 trial(s) available for staurosporine and Cancer of Ovary
| Article | Year |
|---|---|
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neutropenia; Ovarian Neoplasms; Salivary Gland Neoplasms; Staurosporine; Survival Analysis; Topotecan | 2006 |
UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: a study of the Princess Margaret Hospital Phase II consortium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Staurosporine; Topotecan | 2007 |
17 other study(ies) available for staurosporine and Cancer of Ovary
| Article | Year |
|---|---|
Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Ovarian Neoplasms; Pyrans; Pyrimidines; src-Family Kinases; Triazoles | 2011 |
Membrane damaging activity of a maslinic acid analog.
Topics: Cell Line, Tumor; Cell Membrane; Female; Humans; Molecular Structure; Ovarian Neoplasms; Triterpenes | 2014 |
RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.
Topics: Apoptosis; Biomarkers, Pharmacological; Chromosomal Proteins, Non-Histone; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; HeLa Cells; Humans; Lung Neoplasms; Ovarian Neoplasms; rac1 GTP-Binding Protein; Staurosporine | 2018 |
Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Sequestosome-1 Protein; Staurosporine; Tumor Cells, Cultured | 2018 |
[Expression of connexin 43 in ovarian cancer and its relationship with chemoresistance].
Topics: Adult; Aged; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Connexin 43; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gap Junctions; Humans; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Protein Kinase C; Staurosporine; Transfection | 2009 |
Targeting slow-proliferating ovarian cancer cells.
Topics: Antineoplastic Agents; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Disease-Free Survival; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Ovarian Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine | 2010 |
Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells.
Topics: Adenosine Triphosphate; Cell Division; DNA-Binding Proteins; Epithelium; ets-Domain Protein Elk-1; Female; Flavonoids; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Precancerous Conditions; Proto-Oncogene Proteins; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; RNA, Messenger; RNA, Neoplasm; Staurosporine; Transcription Factors; Tumor Cells, Cultured | 2003 |
Apoptosis and differentiation induced by staurosporine in granulosa tumor cells is coupled with activation of JNK and suppression of p38 MAPK.
Topics: Apoptosis; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Female; Granulosa Cell Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Progesterone; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Staurosporine | 2005 |
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells.
Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Female; Humans; Neural Cell Adhesion Molecule L1; Ovarian Neoplasms; Sphingosine; Staurosporine; Transfection | 2007 |
Antitumor and normal cell protective effect of PKC412 in the athymic mouse model of ovarian cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cytokines; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Protein Kinase C; Spleen; Staurosporine; Xenograft Model Antitumor Assays | 2006 |
Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Endometrioid; Carcinoma, Papillary; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Vectors; Humans; Ki-67 Antigen; Microscopy, Fluorescence; Mitochondria; Ovarian Neoplasms; Ovary; Prohibitins; Recombinant Proteins; Repressor Proteins; Resting Phase, Cell Cycle; RNA, Small Interfering; Staurosporine; Up-Regulation | 2008 |
Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle, DNA synthesis and drug uptake in neoplastic cell lines.
Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Cycle; Cytarabine; DNA Replication; DNA, Neoplasm; Drug Resistance, Multiple; Drug Synergism; Female; Humans; Leukemia L1210; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tumor Cells, Cultured | 1995 |
The protein kinase C inhibitor, CGP 41 251, reverses decreased daunomycin uptake in a human drug-resistant ovarian carcinoma cell line.
Topics: Alkaloids; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tumor Cells, Cultured | 1994 |
Interferon-alpha (IFN alpha) induces a cytolytic mechanism in ovarian carcinoma cells through a protein kinase C-dependent pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Analysis of Variance; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Emetine; Female; Humans; Interferon alpha-2; Interferon-alpha; Isoquinolines; Ovarian Neoplasms; Piperazines; Protein Biosynthesis; Protein Kinase C; Recombinant Proteins; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; Cisplatin; Drug Synergism; Female; Genes, p53; Humans; Mutagenesis; Ovarian Neoplasms; Recombinant Proteins; Staurosporine; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |
Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system.
Topics: Cell Division; Cell Line; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Female; Follicle Stimulating Hormone; Humans; Isoenzymes; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Thymidine | 2001 |
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate.
Topics: Alkaloids; Cell Line; Cell Survival; Cisplatin; Female; Humans; Kinetics; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1990 |